Truist Financial’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,256
Closed -$401K 2816
2022
Q1
$401K Buy
15,256
+149
+1% +$3.64K ﹤0.01% 2125
2021
Q4
$358K Hold
15,107
﹤0.01% 2241
2021
Q3
$379K Sell
15,107
-3,143
-17% -$80.1K ﹤0.01% 2187
2021
Q2
$474K Buy
+18,250
New +$497K ﹤0.01% 2092
2020
Q3
Sell
-9,355
Closed -$204K 2610
2020
Q2
$204K Sell
9,355
-16,520
-64% -$378K ﹤0.01% 2180
2020
Q1
$598K Buy
25,875
+6,129
+31% +$178K ﹤0.01% 1489
2019
Q4
$652K Buy
+19,746
New +$633K ﹤0.01% 1690

Other funds holding NTUS

Truist Financial's NTUS Position: Q2 2022 in Review

Truist Financial sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 15,256 shares — an estimated $401K sold.

Truist Financial first reported a position in NTUS in Q4 2019 and held it in 7 quarters. The position peaked at $652K in Q4 2019. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

  • Truist Financial reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Truist Financial sold 15,256 Natus Medical Inc shares in Q2 2022, an estimated $401K.
  • Truist Financial first reported a position in Natus Medical Inc in Q4 2019 and held it in 7 quarters.
  • Truist Financial's Natus Medical Inc position peaked at $652K in Q4 2019.
  • 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Truist Financial's 13F filing for Q2 2022, filed 22 Jul 2022.